Telehealth at the Crossroads
Protecting a Lifeline for Chronic Disease Patients While Closing the Door on Fraud Investigative Policy Analysis · IPCSG Research Series · February 21, 2026 Health Policy & Program Integrity February 21, 2026 · Medicare Policy Analysis Bottom Line Up Front (BLUF) Telehealth is not a luxury for the chronically ill — for cancer patients, dialysis patients, and those managing complex multi-drug regimens, it is a clinically validated, cost-effective necessity. The evidence shows that well-designed telehealth does not increase downstream hospitalizations or emergency visits. The fraud problem is real but traceable to a specific, identifiable set of bad actors — fly-by-night telehealth mills, fraudulent DME schemes, and unscrupulous genetic testing companies — not to the established patient-physician relationships that responsible telehealth protects. The policy solution is not restriction, but pre...